Immune Dynamics in the Natural History of Chronic HBV Infection
1 other identifier
observational
5,000
1 country
1
Brief Summary
The purpose of this observational study is to follow up on chronic HBV-infected patients over a long period of time to understand the changes in the immune status as age increases and the natural history of chronic HBV infection progresses. The main questions it aims to answer are:
- Does the natural history of chronic HBV infection progress with changes in HBV-specific immunity?
- What is the role of age in the natural history of chronic HBV infection? Patients with chronic HBV infection who are untreated and aged 1-80 years will be followed up every six months. During each follow-up, HBV-related serological and virological indicators will be tested. Peripheral blood samples will also be collected to test HBV-specific immunity and the immune environment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2024
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2024
CompletedFirst Submitted
Initial submission to the registry
June 19, 2025
CompletedFirst Posted
Study publicly available on registry
August 22, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2040
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2041
September 30, 2025
September 1, 2025
16.8 years
June 19, 2025
September 28, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
In accordance with the 2018 AASLD Hepatitis B guidelines, the natural history of HBV is staged based on the laboratory test results (HBV serological markers, viral load, and liver function) and imaging findings of the enrolled patients.
Enrolled patients will undergo examinations of HBV serological markers, viral load, liver function, liver ultrasound, and liver fibrosis every six months. Subsequently, based on the 2018 AASLD Hepatitis B guidelines , patients will be staged to observe whether there are changes in the natural history of hepatitis B.
over a follow-up period of 5 years
Secondary Outcomes (1)
The HBV-specific immune response levels will be measured using the immune cells of the enrolled patients
over a follow-up period of five years
Study Arms (1)
Chronic hepatitis B virus (HBV) infection
Patients with chronic HBV infection who are untreated and aged 1-80 years. Follow-ups will be conducted every six months, with a minimum of six visit points.
Interventions
For adults (including those who are 18 years old): During the routine follow-up visits, an extra 30 milliliters of peripheral blood will be drawn. For minors (under 18 years old): During the routine follow-up visits, an extra 6 milliliters of peripheral blood will be drawn. Follow-ups will be conducted every six months, with a minimum of six visit points.
Eligibility Criteria
The study population consists of chronic hepatitis B patients who have not received antiviral therapy within the past six months.
You may qualify if:
- Aged 1-80 years, either male or female.
- Patients diagnosed with chronic hepatitis B virus infection in accordance with the "Guidelines for the Prevention and Treatment of Chronic Hepatitis B" (2019 edition).
- No antiviral treatment (including nucleoside analogs and interferons, etc.) within the past six months.
You may not qualify if:
- Other Unsuitable Conditions:
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Nanfang Hospital, Southern Medical University
Guangzhou, Guangdong, 510515, China
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 3 Years
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 19, 2025
First Posted
August 22, 2025
Study Start
February 1, 2024
Primary Completion (Estimated)
December 1, 2040
Study Completion (Estimated)
December 1, 2041
Last Updated
September 30, 2025
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will not share